2009-11-25
(WASHINGTON) - The American Society of
Hematology (ASH), the world’s largest professional society of blood
specialists, will recognize a member of the U.S. House of Representatives and
the national spokesperson for the Coalition to Prevent Deep-Vein Thrombosis for
their efforts to promote biomedical research. The Public Service awards will be
announced in conjunction with the Society’s 51st Annual Meeting in New Orleans, LA.
Melanie Bloom, national spokesperson for the Coalition to
Prevent Deep-Vein Thrombosis (DVT), will be honored with ASH’s Outstanding
Service Award for her dedication to increasing public awareness of DVT. Following
the death of her husband, award-winning NBC TV journalist David Bloom, who died
from complications related to DVT while on assignment in Iraq, Ms. Bloom has
worked to share her personal story to raise awareness and educate patients,
health-care professionals, and policy makers about reducing the risk of DVT. In
addition to helping to garner support to declare March as DVT Awareness Month
and serving on the Steering Committee for the National
Quality Forum to help establish consensus on DVT treatment guidelines, Ms.
Bloom spoke
as part of the ASH Special Session on Venous Thromboembolism at the 2007 ASH
Annual Meeting in Atlanta.
Rep. Doris O. Matsui (D-CA) will
receive ASH’s Award for Public Service for her dedication
to health-care issues. Since winning a special election in 2005 to fill
the remainder of the term of her late husband, who died from
complications of myelodysplastic syndrome (MDS), Rep. Matsui has been a champion of health-care
and research issues. As a member of the House Energy and Commerce
Committee, which oversees most non-Medicare/Medicaid health-related issues in
the House, and because of her personal experience with MDS, Rep. Matsui has
been particularly active in issues related to bone marrow failures and
hematologic malignancies, and has sponsored legislation to improve research and
treatment of bone marrow diseases. She has also helped to lead
congressional efforts to secure dedicated blood cancer research funding at the
Department of Defense.
“The hematology community owes both
of these women a great debt for their outstanding leadership and tireless
efforts to help advance the cause of medical research,” said Nancy Berliner,
MD, 2009 ASH President, Chief of Hematology at Brigham and Women’s Hospital in
Boston, MA, and Professor of Medicine at Harvard Medical School. “It is my honor to recognize these two
distinguished individuals for their dedication to achieving better
understanding of and treatment for hematologic disorders.”
The awards will be formally announced
on Sunday, December 6, at 1:30 p.m. prior to the Plenary Scientific Session.
Reporters who wish to arrange an
interview may contact Patrick C. Irelan, ASH Communications Assistant, at
202-776-0544 or pirelan@hematology.org.
The American Society of Hematology (www.hematology.org) is the world’s largest
professional society concerned with the causes and treatment of blood
disorders. Its mission is to further the understanding, diagnosis, treatment,
and prevention of disorders affecting blood, bone marrow, and the immunologic,
hemostatic, and vascular systems, by promoting research, clinical care,
education, training, and advocacy in hematology. ASH provides Blood: The Vital Connection (www.bloodthevitalconnection.org),
a credible online resource addressing bleeding and clotting disorders, anemia,
and cancer. The official journal of ASH is Blood
(www.bloodjournal.org), the most cited
peer-reviewed publication in the field, which is available weekly in print and
online.
back to top